Stock Traders Buy Large Volume of SPDR S&P Biotech ETF Call Options (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of unusually large options trading activity on Thursday. Stock traders purchased 57,758 call options on the company. This represents an increase of 47% compared to the average daily volume of 39,379 call options.

SPDR S&P Biotech ETF Trading Down 3.6%

NYSEARCA:XBI traded down $5.46 on Friday, hitting $144.32. The company had a trading volume of 11,754,034 shares, compared to its average volume of 9,186,571. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The stock has a market capitalization of $9.90 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The firm has a 50 day moving average of $158.09 and a two-hundred day moving average of $146.87.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Axiom Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $26,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $27,000. Angeles Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter worth about $28,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $31,000. Finally, Morling Financial Advisors LLC bought a new position in SPDR S&P Biotech ETF in the second quarter valued at about $36,000.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.